PHARMACEUTICAL COMBINATIONS COMPRISING TEGASEROD UND OMEPRAZOLE AND THEIR USE IN TREATING GASTROINTESTINAL DISORDERS

The present invention relates to a combination of a first agent inducing either a 5-HT 4 receptor agonist or antagonist or a 5-HT 3 receptor antagonist and a co-agent and pharmaceutical compositions and formulations containing the combination. The pharmaceutical combination may be employed for the t...

Full description

Saved in:
Bibliographic Details
Main Authors WILUSZ, EDWARD, JOSEPH, JR, BILLSTEIN, STEPHAN, ANTHONY, IWICKI, MARK, THOMAS, DUMOVIC, PETER, FRANCO, NICOLA, PFANNKUCHE, HANS-JUERGEN
Format Patent
LanguageEnglish
French
German
Published 27.04.2005
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a combination of a first agent inducing either a 5-HT 4 receptor agonist or antagonist or a 5-HT 3 receptor antagonist and a co-agent and pharmaceutical compositions and formulations containing the combination. The pharmaceutical combination may be employed for the treatment of altered gastrointestinal motility, sensitivity, secretion or abdominal disorders. The dosage is preferably oral. The preferred first agent is tegaserod.
Bibliography:Application Number: EP20000989967